ROSSI, GIUSEPPE
 Distribuzione geografica
Continente #
NA - Nord America 258
EU - Europa 146
AS - Asia 88
AF - Africa 12
SA - Sud America 2
Totale 506
Nazione #
US - Stati Uniti d'America 257
GB - Regno Unito 46
VN - Vietnam 37
SE - Svezia 27
IT - Italia 22
CN - Cina 21
DE - Germania 16
SG - Singapore 15
IN - India 10
FR - Francia 8
IE - Irlanda 8
RU - Federazione Russa 7
CH - Svizzera 5
TG - Togo 5
EE - Estonia 4
JO - Giordania 3
ZA - Sudafrica 3
BG - Bulgaria 2
CI - Costa d'Avorio 2
HK - Hong Kong 2
NG - Nigeria 2
AR - Argentina 1
BR - Brasile 1
MX - Messico 1
UA - Ucraina 1
Totale 506
Città #
Houston 49
Southend 40
Dong Ket 37
Chandler 30
Fairfield 27
Ashburn 17
Seattle 17
Woodbridge 16
Singapore 14
Cambridge 12
Wilmington 11
Dublin 8
Princeton 8
Santa Clara 8
Boardman 7
Bern 5
Lomé 5
Nanjing 5
Farra d'Isonzo 4
New York 4
Padova 4
Westminster 4
Amman 3
Ann Arbor 3
Beijing 3
Norwalk 3
Abeokuta 2
Abidjan 2
Berlin 2
Brescia 2
Central District 2
Jiaxing 2
London 2
Medford 2
Phoenix 2
Saint Petersburg 2
Sofia 2
Tianjin 2
Turin 2
Bologna 1
Bremen 1
Buenos Aires 1
Frankfurt Am Main 1
Guangzhou 1
Jinan 1
Madero 1
Nanchang 1
Reggio Nell'emilia 1
Riva 1
Rome 1
Santiago 1
Secunderabad 1
Shanghai 1
Shenyang 1
Shenzhen 1
Shijiazhuang 1
Taizhou 1
Trieste 1
Totale 389
Nome #
Assessment of BCR-ABL1 Transcript Levels By Digital PCR (dPCR) in CML Patients who Achieved a Deep Molecular Response (DMR: MR4.0, MR4.5 And MR5.0) with Tkis May Improve the Detection of Minimal Residual Disease (MRD) and the Selection of Patients for Treatment Free Remission (TFR) 162
Interim positron emission tomography response-adapted therapy in advanced-stage hodgkin lymphoma: Final results of the phase II part of the HD0801 study 149
The efficacy of lenalidomide combination therapy in heavily pretreated non-Hodgkin lymphoma patients: an Italian observational, multicenter, retrospective study 105
Digital PCR (dPCR) Overcomes the Limitations in Detection and in Quantification of Quantitative PCR (qPCR) and Reveals Different Levels of BCR-ABL1 Copies/µl Among the Chronic Myeloid Leukemia (CML) Patients Achieving Major (MR3.0) or DEEP (MR4.0, MR4.5 and MR5.0) Molecular Response with Tyrosin Kynase Inhibitors (TKIs) 100
Totale 516
Categoria #
all - tutte 1.201
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.201


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020106 0 0 0 0 0 45 12 14 14 8 6 7
2020/202174 10 3 0 1 2 2 0 3 6 4 1 42
2021/202266 5 1 4 8 8 5 1 3 4 5 9 13
2022/2023114 14 15 5 18 6 7 3 6 19 2 10 9
2023/202417 2 0 0 2 1 7 0 2 0 0 0 3
2024/202536 1 8 7 2 16 2 0 0 0 0 0 0
Totale 516